The interferon-inducible antiviral protein Daxx is not essential for interferon-mediated protection against avian sarcoma virus
Open Access
- 28 May 2014
- journal article
- Published by Springer Nature in Virology Journal
- Vol. 11 (1) , 100
Abstract
The antiviral protein Daxx acts as a restriction factor of avian sarcoma virus (ASV; Retroviridae) in mammalian cells by promoting epigenetic silencing of integrated proviral DNA. Although Daxx is encoded by a type I (α/β) interferon-stimulated gene, the requirement for Daxx in the interferon anti-retroviral response has not been elucidated. In this report, we describe the results of experiments designed to investigate the role of Daxx in the type I interferon-induced anti-ASV response.Keywords
This publication has 18 references indexed in Scilit:
- Retroviral DNA Methylation and Epigenetic Repression Are Mediated by the Antiviral Host Protein DaxxJournal of Virology, 2013
- Mechanisms of type-I- and type-II-interferon-mediated signallingNature Reviews Immunology, 2005
- The Cellular Protein Daxx Interacts with Avian Sarcoma Virus Integrase and Viral DNA To Repress Viral TranscriptionJournal of Virology, 2005
- A FADD-dependent innate immune mechanism in mammalian cellsNature, 2004
- Defective translational control facilitates vesicular stomatitis virus oncolysisCancer Cell, 2004
- VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsCancer Cell, 2003
- Genetically Engineered Vesicular Stomatitis Virus in Gene Therapy: Application for Treatment of Malignant DiseaseJournal of Virology, 2002
- The EV-O-Derived Cell Line DF-1 Supports the Efficient Replication of Avian Leukosis-Sarcoma Viruses and VectorsVirology, 1998
- HOW CELLS RESPOND TO INTERFERONSAnnual Review of Biochemistry, 1998
- Daxx, a Novel Fas-Binding Protein That Activates JNK and ApoptosisCell, 1997